Atlas Trials

Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients

Clinical trial NCT06615752 · RECRUITING

Trial details

NCT number
NCT06615752
Sponsor
Charles Drew University of Medicine and Science
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Start date
2026-10-01
Primary completion
2028-04-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.